1. (1) The purpose of this rule is to establish licensing and regulatory requirements for a stand-alone Medicare PDP.
2. (2) This rule applies to a person that offers a stand-alone Medicare PDP.

KEY: prescription drug plans

Date of Last Change: December 8, 2022

Notice of Continuation: April 6, 2026

Authorizing, and Implemented or Interpreted Law: 31A-2-201